Source: United Press International
Inovio Pharmaceuticals has received a $3.5 billion grant from the National Institute of Allergy and Infectious Diseases to further development of a new device that would administer several vaccines at once. For the public/private partnership, Inovio will work with the U.S. Army Medical Research Institute of Infectious Diseases to develop a product that would deliver multiple synthetic vaccines to U.S. troops as well as civilian populations in case of a pandemic. “This new device would provide a means to rapidly and painlessly deliver multiple vaccines simultaneously to large groups of people,” said Dr. J. Joseph Kim, Inovio’s president and chief executive officer. “This collaboration builds on Inovio’s strong relationship with Dr. Connie Schmaljohn and her team at USAMRIID in which Inovio is bringing medical innovation to several biodefense efforts.”
Copyright © 2014 Information, Inc.